The Therapeutic Momentum podcast series illuminates the inspiring personal stories, touchstone moments, and transformational events that fuel the relentless pursuit of life-changing treatments. It reveals the intricate tapestry of experiences that drive people in the biomedical field who share the collective goal of improving patient outcomes. We hope to offer listeners a multifaceted perspective on the diverse talent and backgrounds of people working towards better health and hope for patients.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
34%
Guest openness
Selective
Sign up to generate a grounded pitch for Therapeutic Momentum.
Signup to Generate a PitchThe Therapeutic Momentum podcast series illuminates the inspiring personal stories, touchstone moments, and transformational events that fuel the relentless pursuit of life-changing treatments. It reveals the intricate tapestry of experiences that drive people in the biomedical field who share the collective goal of improving patient outcomes.
Recent episodes include "Kate Haviland: The Bilingual Biotech Leader Behind Blueprint's $9.5B Sanofi Deal" (16 May 2026, 54 minutes), "Kate Haviland: The Bilingual Biotech Leader Behind Blueprint's $9.5B Sanofi Deal" (16 May 2026, 54 minutes), and "AI + Life Sciences: Why the Future Needs Both Human Brains and Wet Labs" (11 April 2026, 58 minutes).
Therapeutic Momentum publishes roughly every two weeks, with episodes averaging 50 minutes across 8 episodes.
Booking probability for Therapeutic Momentum is 34%, and the host is rated Selective on guests. Therapeutic Momentum requires a Pod Score of 80 or higher. Therapeutic Momentum's contact route on record: public web form.
The strongest fits for Therapeutic Momentum are Scientific Research & Development. Therapeutic Momentum has a science audience.
Therapeutic Momentum is a science podcast with 8 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Therapeutic Momentum
In this episode I am joined by Kate Haviland, who most recently served as President and CEO of Blueprint Medicines, guiding it from a clinical-stage company through a fully integrated commercial business and ultimately...
<p>In this episode I am joined by Kate Haviland, who most recently served as President and CEO of Blueprint Medicines, guiding it from a clinical-stage company through a fully integrated commercial business and...
Therapeutic Momentum
<p>In this episode, I speak with Sam Scarpino, Director of AI and Life Sciences at Northeastern University's Institute for Experiential AI and Professor of Public Health and Health Sciences. With a background spanning...
Therapeutic Momentum
In this episode, I speak with Sam Scarpino, Director of AI and Life Sciences at Northeastern University's Institute for Experiential AI and Professor of Public Health and Health Sciences. With a background spanning...
<p>Robert Plenge is a physician-scientist known for his work at Merck, Celgene, and BMS, translating insights from human genetics into breakthroughs in drug discovery and development, resulting in new medicines. On his...
Episode #4
<p>Dame Catherine Elizabeth "Kate" Bingham is a British biochemist and life‑sciences venture capitalist. She earned a first‑class MA in Biochemistry from Oxford and an MBA (Baker Scholar) from Harvard. Since 1991, she...
Episode #4
<p>Dame Catherine Elizabeth "Kate" Bingham is a British biochemist and life‑sciences venture capitalist. She earned a first‑class MA in Biochemistry from Oxford and an MBA (Baker Scholar) from Harvard. Since 1991, she...
<p>Mathai Mammen is a world-renowned innovator in drug discovery, development, and team- and company-building responsible for creating 13 transformational medicines from discovery through commercial launch and more than...
<p>The Therapeutic Momentum podcast series illuminates the inspiring personal stories, touchstone moments, and transformational events that fuel the relentless pursuit of life-changing treatments. It reveals the...
<p>Andy Plump discusses his journey from a postdoc at UCSF to a leading roles in pharmaceutical research. Andy, who joined Merck in 2001, worked in clinical pharmacology. He highlighted the importance of genetics in...
<p>Coronary heart disease is no longer a mystery. Listen to the story of one of medicine’s greatest triumphs — a battle fought in labs, clinics, kitchens, and boardrooms. This is the story of cholesterol. And how we...
Recent guests on Therapeutic Momentum. Study who booked and why before you pitch.
Dame Commander of the British Empire
CEO, President and Chairman, Janssen Pharmaceutical Companies of Johnson & Johnson
Blueprint Medicines
Northeastern University's Institute for Experiential AI
PitchCentric classifies Therapeutic Momentum under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
